Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biosimilars
biosimilars
Biogen adds a late-stage prospect to its growing biosimilar business
BioPharma Dive
Thu, 04/8/21 - 07:44 pm
Biogen
Actemra
anti-inflammatories
biosimilars
COVID-19
Pfizer halts biosimilar programs in crowded China market, sells plant to WuXi Biologics
Fierce Pharma
Wed, 03/17/21 - 11:39 pm
Pfizer
China
biosimilars
WuXi Biologics
Generics companies face risk as SCOTUS questions patent tribunal’s constitutionality
MedCity News
Fri, 03/5/21 - 10:24 am
generics
Supreme Court
patents
biosimilars
devices
The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA
Drug Patent Watch
Wed, 02/3/21 - 10:52 pm
regulatory
biosimilars
Europe
EMA
FDA
The More You Know: FDA Provides Additional Guidance on Biosimilars
FDA Law Blog
Wed, 12/16/20 - 10:57 am
FDA
biosimilars
Roche yields to cancer biosim competition by offering 'relevant' discounts: report
Fierce Pharma
Thu, 12/10/20 - 07:19 pm
Roche
biosimilars
CMS
discounts
buy-and-bill
Samsung Biologics, AstraZeneca to dissolve biosimilar JV, scrap Rituxan copy program: report
Fierce Pharma
Thu, 11/19/20 - 08:29 pm
Samsung BioLogics
AstraZeneca
Rituxan
Roche
biosimilars
Archigen Biotech
FDA begins review of Samsung Bioepis/Biogen’s Lucentis biosimilar
Pharmaforum
Thu, 11/19/20 - 10:33 am
Novartis
Genentech
Lucentis
biosimilars
Samsung Bioepis
Biogen
FDA
Testing requirements are likely slowing biosimilar entries in the US
RAPS.org
Wed, 10/14/20 - 05:53 pm
biosimilars
regulatory
patents
drug rebates
Sandoz working to overcome barriers to greater biosimilars uptake in US
Biopharma Reporter
Mon, 09/21/20 - 10:55 am
Sandoz
biosimilars
Novartis
Biocon and Mylan Launch Semglee; Biosimilar, Interchangeable Status Are Sought
Center for Biosimilars
Tue, 09/1/20 - 10:44 am
Biocon
Mylan
Semglee
generics
insulin
diabetes
biosimilars
Pfizer's Unheralded Franchise That's Worth Billions of Dollars
Motley Fool
Sun, 08/16/20 - 10:44 pm
Pfizer
biosimilars
Humira
Inflectra
Remsima
Remicade
autoimmune disease
JNJ
Amgen's Enbrel Patents to Be Upheld Through 2029
Motley Fool
Thu, 07/2/20 - 12:15 am
psoriasis
rheumatoid arthritis
Enbrel
Novartis
biosimilars
patents
AbbVie's Humira defense may keep prices high, but it's still legal, judge rules
Fierce Pharma
Tue, 06/9/20 - 12:11 pm
AbbVie
Humira
biosimilars
patents
Most big commercial health plans rarely prefer biosimilars
Beckers Hospital Review
Thu, 05/21/20 - 10:23 am
insurers
biosimilars
COVID-19 restrictions send generic drug shipping costs through the roof: survey
Fierce Pharma
Sat, 05/2/20 - 11:21 pm
COVID-19
generics
biosimilars
drug manufacturing
Amgen/Allergan’s rituximab biosimilar could be $4bn blockbuster
Pharmaforum
Wed, 03/11/20 - 10:45 am
Amgen
Allergan
biosimilars
Roche
rituximab
Biosimilar sales to reach $6.5B by 2024, study says
Beckers Hospital Review
Tue, 03/10/20 - 11:25 pm
biosimilars
10 Drugs Expected to Enter the Market This Year Could be Blockbusters, Analysis Says
BioSpace
Mon, 03/9/20 - 11:10 pm
biosimilars
Amgen
Allergan
Roche
Rituxan
Bristol-Myers Squibb
ozanimod
risdiplam
Biomarin
valrox
Is Merck a Better Buy After Announcing Spinoff?
Motley Fool
Mon, 02/24/20 - 10:43 am
Merck
spinoffs
Women's Health
biosimilars
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »